Bristol-Myers buys Orbital Therapeutics for $1.5 billion
Drugmaker Bristol-Myers Squibb said on Friday it will acquire privately held cell therapy developer Orbital Therapeutics for $1.5 billion in cash.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Orbital Therapeutics
since
auto-detected in 1 stories
58 days ago
page 1 of 1